Monte Financial Statements From 2010 to 2026

GLUE Stock

USD 18.96 0.61 3.12%

Monte Rosa's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Monte Rosa's valuation are provided below:

Gross Profit

51 M

Profit Margin

0.1154

Market Capitalization

1.5 B

Enterprise Value Revenue

6.2914

Revenue

181.5 M

There are over one hundred nineteen available fundamental ratios for Monte Rosa, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of Monte Rosa's last-minute performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 729.1 M. The current year's Enterprise Value is expected to grow to about 619.7 M

Monte Rosa Total Revenue

91.31 Million

Check Monte Rosa financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Monte Rosa's main balance sheet or income statement drivers, such as Net Interest Income of 12.8 M, Depreciation And Amortization of 9.8 M or Interest Expense of 4.5 M, as well as many indicators such as Price To Sales Ratio of 5.42, Dividend Yield of 0.0 or PTB Ratio of 2.17. Monte financial statements analysis is a perfect complement when working with Monte Rosa Valuation or Volatility modules.

Build AI portfolio with Monte Stock

Check out the analysis of Monte Rosa Correlation against competitors.

Monte Rosa Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

277.1 M

504.5 M

140.8 M

Slightly volatile

Short and Long Term Debt Total

44.9 M

49.1 M

20.7 M

Slightly volatile

Other Current Liabilities

14.8 M

21.6 M

7.1 M

Slightly volatile

Total Current Liabilities

189.5 M

180.5 M

40.5 M

Slightly volatile

Property Plant And Equipment Net

36.5 M

64.8 M

18.4 M

Slightly volatile

Accounts Payable

20.8 M

19.8 M

7.2 M

Slightly volatile

Cash

146.9 M

257.9 M

74.1 M

Slightly volatile

Non Current Assets Total

40.4 M

70.5 M

20.2 M

Slightly volatile

Cash And Short Term Investments

231.2 M

428 M

116.1 M

Slightly volatile

Net Receivables

189 K

198.9 K

998.1 K

Slightly volatile

Common Stock Total Equity

4.3 K

4.5 K

31.2 K

Slightly volatile

Common Stock Shares Outstanding

56.3 M

85 M

49.7 M

Slightly volatile

Liabilities And Stockholders Equity

277.1 M

504.5 M

140.8 M

Slightly volatile

Non Current Liabilities Total

49.9 M

67.7 M

33 M

Slightly volatile

Other Current Assets

4 M

5.9 M

3.9 M

Slightly volatile

Other Stockholder Equity

401.2 M

764.6 M

197.3 M

Slightly volatile

Total Liabilities

260.6 M

248.2 M

74.7 M

Slightly volatile

Property Plant And Equipment Gross

92.6 M

88.2 M

25.1 M

Slightly volatile

Short and Long Term Debt

600 K

675 K

736.8 K

Slightly volatile

Total Current Assets

236.8 M

434.1 M

120.6 M

Slightly volatile

Capital Stock

9.6 K

5.4 K

31.6 K

Slightly volatile

Net Working Capital

185.6 M

253.6 M

88.3 M

Slightly volatile

Short Term Debt

3 M

4.3 M

1.8 M

Slightly volatile

Common Stock

9.6 K

5.4 K

31.6 K

Slightly volatile

Property Plant Equipment

32.7 M

31.1 M

10.3 M

Slightly volatile

Other Liabilities

1.8 M

1.3 M

Slightly volatile

Non Currrent Assets Other

4.6 M

5.7 M

2.5 M

Slightly volatile

Other Assets

4.1 M

5.3 M

2.4 M

Slightly volatile

Capital Surpluse

536.4 M

579.3 M

487.4 M

Slightly volatile

Non Current Liabilities Other

26.2 M

52.2 M

14.2 M

Slightly volatile

Inventory

768 K

864 K

943.1 K

Slightly volatile

Current Deferred Revenue

74.2 M

134.8 M

33.7 M

Slightly volatile

Monte Rosa Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

9.8 M

9.3 M

2.4 M

Slightly volatile

Interest Expense

4.5 M

4.3 M

1.3 M

Slightly volatile

Selling General Administrative

21.1 M

40.4 M

10.7 M

Slightly volatile

Other Operating Expenses

95.6 M

180.2 M

51.1 M

Slightly volatile

Research Development

73.3 M

139.8 M

39.9 M

Slightly volatile

Cost Of Revenue

4.7 M

9.3 M

2.4 M

Slightly volatile

Total Operating Expenses

92.8 M

170.9 M

49.5 M

Slightly volatile

Reconciled Depreciation

9.8 M

9.3 M

2.3 M

Slightly volatile

Interest Income

12.8 M

12.2 M

2.8 M

Slightly volatile

Selling And Marketing Expenses

7.6 M

8.5 M

9.3 M

Slightly volatile

Monte Rosa Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Net Borrowings

7.2 M

8.1 M

8.8 M

Slightly volatile

Begin Period Cash Flow

109.7 M

152.6 M

51.6 M

Slightly volatile

Other Cashflows From Financing Activities

62.5 M

113.4 M

38 M

Slightly volatile

Depreciation

9.8 M

9.3 M

2.4 M

Slightly volatile

Capital Expenditures

4.4 M

4.6 M

4.2 M

Slightly volatile

Total Cash From Financing Activities

79.9 M

89 M

53.1 M

Slightly volatile

End Period Cash Flow

151.1 M

263.5 M

77.8 M

Slightly volatile

Change To Liabilities

245.4 K

258.3 K

20.8 M

Slightly volatile

Cash Flows Other Operating

800 K

571.5 K

1.2 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

5.42

6.1

6.6625

Slightly volatile

Days Sales Outstanding

0.67

0.75

0.8203

Slightly volatile

Stock Based Compensation To Revenue

0.19

0.22

0.2356

Slightly volatile

Capex To Depreciation

0.54

0.56

12.4315

Slightly volatile

EV To Sales

3.5

3.94

4.3044

Slightly volatile

Payables Turnover

0.22

0.42

0.1816

Slightly volatile

Sales General And Administrative To Revenue

0.38

0.42

0.4574

Slightly volatile

Research And Ddevelopement To Revenue

1.29

1.45

1.5796

Slightly volatile

Capex To Revenue

0.0422

0.0475

0.0518

Slightly volatile

Cash Per Share

3.15

4.53

1.9146

Slightly volatile

Days Payables Outstanding

845

890

10.1 K

Slightly volatile

Current Ratio

2.06

2.16

3.9804

Pretty Stable

Receivables Turnover

350

393

429

Slightly volatile

Capex Per Share

0.0461

0.0486

0.082

Slightly volatile

Revenue Per Share

0.82

0.92

1.0051

Slightly volatile

Interest Debt Per Share

0.66

0.52

0.3832

Slightly volatile

Debt To Assets

0.11

0.0974

0.1642

Pretty Stable

Operating Cycle

0.67

0.75

0.8203

Slightly volatile

Days Of Payables Outstanding

845

890

10.1 K

Slightly volatile

Ebt Per Ebit

1.11

0.99

0.9912

Pretty Stable

Long Term Debt To Capitalization

2.85

3.2

3.4969

Slightly volatile

Quick Ratio

2.06

2.16

3.9804

Pretty Stable

Net Income Per E B T

0.82

0.93

1.0091

Slightly volatile

Cash Ratio

1.56

1.64

2.6893

Pretty Stable

Operating Cash Flow Sales Ratio

0.45

0.5

0.5459

Slightly volatile

Days Of Sales Outstanding

0.67

0.75

0.8203

Slightly volatile

Free Cash Flow Operating Cash Flow Ratio

1.29

1.04

1.1979

Pretty Stable

Fixed Asset Turnover

1.07

1.21

1.319

Slightly volatile

Debt Ratio

0.11

0.0974

0.1642

Pretty Stable

Price Sales Ratio

5.42

6.1

6.6625

Slightly volatile

Asset Turnover

0.14

0.16

0.1697

Slightly volatile

Gross Profit Margin

0.71

0.8

0.8764

Slightly volatile

Monte Rosa Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

729.1 M

589.9 M

804.9 M

Slightly volatile

Enterprise Value

619.7 M

381.1 M

748.3 M

Slightly volatile

Monte Fundamental Market Drivers

	Forward Price Earnings	10.02
	Cash And Short Term Investments	372.1 M

Monte Upcoming Events

	21st of March 2024 Upcoming Quarterly Report	View
	9th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	21st of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About Monte Rosa Financial Statements

Monte Rosa stakeholders use historical fundamental indicators, such as Monte Rosa's revenue or net income, to determine how well the company is positioned to perform in the future. Although Monte Rosa investors may analyze each financial statement separately, they are all interrelated. For example, changes in Monte Rosa's assets and liabilities are reflected in the revenues and expenses on Monte Rosa's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Monte Rosa Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Current Deferred Revenue	134.8 M	74.2 M
Total Revenue	87 M	91.3 M
Cost Of Revenue	9.3 M	4.7 M
Stock Based Compensation To Revenue	0.22	0.19
Sales General And Administrative To Revenue	0.42	0.38
Research And Ddevelopement To Revenue	1.45	1.29
Capex To Revenue	0.05	0.04
Revenue Per Share	0.92	0.82
Ebit Per Revenue	(0.97)	(1.01)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Monte Rosa Therapeutics is a strong investment it is important to analyze Monte Rosa's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monte Rosa's future performance. For an informed investment choice regarding Monte Stock, refer to the following important reports:

How To Invest In Monte

Details

Is Monte Stock a good investment?

Details

What is Monte Rosa's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Monte Rosa Correlation against competitors.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Will Biotechnology sector continue expanding? Could Monte diversify its offerings? Factors like these will boost the valuation of Monte Rosa. Market participants price Monte higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Monte Rosa data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Earnings Share

0.32

Revenue Per Share

2.208

Quarterly Revenue Growth

0.385

Return On Assets

0.0137

Return On Equity

0.0928

Monte Rosa Therapeutics's market price often diverges from its book value, the accounting figure shown on Monte's balance sheet. Smart investors calculate Monte Rosa's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Monte Rosa's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Monte Financial Statements From 2010 to 2026

Monte Rosa Total Revenue

91.31 Million

Monte Rosa Balance Sheet

Monte Rosa Income Statement

Monte Rosa Cash Flow Statement

Financial Ratios

Monte Rosa Valuation Data

Monte Fundamental Market Drivers

Monte Upcoming Events

About Monte Rosa Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY